Prof. Dr. med. Stephan Brand
Gastroenterologie | Hepatologie · Dept. I
Correlation of magnetic resonance enteroclysis (MRE) and wireless capsule endoscopy (CE) in the diagnosis of small bowel lesions in Crohn's disease
Tillack C, Seiderer J, Brand S, Göke B, Reiser M, Schaefer C, Diepolder H, Ochsenkühn T, Herrmann K. Correlation of magnetic resonance enteroclysis (MRE) and wireless capsule endoscopy (CE) in the diagnosis of small bowel lesions in Crohn's disease. Inflamm Bowel Dis 2008; 14:1219-28.
01.09.2008Correlation of magnetic resonance enteroclysis (MRE) and wireless capsule endoscopy (CE) in the diagnosis of small bowel lesions in Crohn's disease
01.09.2008Inflamm Bowel Dis 2008; 14:1219-28
Tillack Cornelia, Seiderer Julia, Brand Stephan, Göke Burkhard, Reiser Maximilian F, Schaefer Claus, Diepolder Helmut, Ochsenkühn Thomas, Herrmann Karin A
Human beta defensin 2 promotes intestinal wound healing in vitro
Otte J, Werner I, Brand S, Chromik A, Schmitz F, Kleine M, Schmidt W. Human beta defensin 2 promotes intestinal wound healing in vitro. J Cell Biochem 2008; 104:2286-97.
15.08.2008Human beta defensin 2 promotes intestinal wound healing in vitro
15.08.2008J Cell Biochem 2008; 104:2286-97
Otte Jan-Michel, Werner Ilka, Brand Stephan, Chromik Ansgar M, Schmitz Frank, Kleine Michael, Schmidt Wolfgang E
NOD2/CARD15 genotype influences MDP-induced cytokine release and basal IL-12p40 levels in primary isolated peripheral blood monocytes
Beynon V, Glas J, Folwaczny C, Folwaczny M, Ochsenkühn T, Mussack T, Wagner S, Mair A, Lohse P, Brand S, Cotofana S, Török H. NOD2/CARD15 genotype influences MDP-induced cytokine release and basal IL-12p40 levels in primary isolated peripheral blood monocytes. Inflamm Bowel Dis 2008; 14:1033-40.
01.08.2008NOD2/CARD15 genotype influences MDP-induced cytokine release and basal IL-12p40 levels in primary isolated peripheral blood monocytes
01.08.2008Inflamm Bowel Dis 2008; 14:1033-40
Beynon Vanessa, Glas Jürgen, Folwaczny Christian, Folwaczny Matthias, Ochsenkühn Thomas, Mussack Thomas, Wagner Stefanie, Mair Anja, Lohse Peter, Brand Stephan, Cotofana Sebastian, Török Helga-Paula
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors
Storr M, Patel K, Brand S, Göke B, Lutz B, Buckley N, Massa F, Sibaev A, Yüce B, Zhang H, Emmerdinger D, Keenan C, Sharkey K. Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors. J Mol Med 2008; 86:925-36.
21.05.2008Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors
21.05.2008J Mol Med 2008; 86:925-36
Storr Martin A, Patel Kamala D, Brand Stephan, Göke Burkhard, Lutz Beat, Buckley Nancy E, Massa Federico, Sibaev Andrei, Yüce Birol, Zhang Hong, Emmerdinger Dominik, Keenan Catherine M, Sharkey Keith A
The role of the novel Th17 cytokine IL-26 in intestinal inflammation
Dambacher J, Beigel F, Zitzmann K, De Toni E, Göke B, Diepolder H, Auernhammer C, Brand S. The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut 2008; 58:1207-17.
15.05.2008The role of the novel Th17 cytokine IL-26 in intestinal inflammation
15.05.2008Gut 2008; 58:1207-17
Dambacher J, Beigel F, Zitzmann K, De Toni E N, Göke B, Diepolder H M, Auernhammer C J, Brand Stephan
Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis
Pusl T, Wild N, Vennegeerts T, Wimmer R, Göke B, Brand S, Rust C. Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis. Biochem Biophys Res Commun 2008; 371:441-5.
29.04.2008Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis
29.04.2008Biochem Biophys Res Commun 2008; 371:441-5
Pusl Thomas, Wild Nadine, Vennegeerts Timo, Wimmer Ralf, Göke Burkhard, Brand Stephan, Rust Christian
Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD
Seiderer J, Lohse P, Müller-Myhsok B, Ochsenkühn T, Göke B, Konrad A, Schmechel S, Jürgens M, Pfennig S, Tillack C, Stallhofer J, Glas J, Diegelmann J, Elben I, Brand S. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 2008; 14:437-45.
01.04.2008Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD
01.04.2008Inflamm Bowel Dis 2008; 14:437-45
Seiderer Julia, Lohse Peter, Müller-Myhsok Bertram, Ochsenkühn Thomas, Göke Burkhard, Konrad Astrid, Schmechel Silke, Jürgens Matthias, Pfennig Simone, Tillack Cornelia, Stallhofer Johannes, Glas Jürgen, Diegelmann Julia, Elben Ira, Brand Stephan
Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status
Schmechel S, Konrad A, Diegelmann J, Glas J, Wetzke M, Paschos E, Lohse P, Göke B, Brand S. Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status. Inflamm Bowel Dis 2008; 14:204-12.
01.02.2008Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status
01.02.2008Inflamm Bowel Dis 2008; 14:204-12
Schmechel Silke, Konrad Astrid, Diegelmann Julia, Glas Jürgen, Wetzke Martin, Paschos Ekaterini, Lohse Peter, Göke Burkhard, Brand Stephan
Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease
Seiderer J, Reinecker H, Lohse P, Ochsenkühn T, Göke B, Müller-Myhsok B, Jürgens M, Pfennig S, Niess J, Glas J, Tillack C, Leistner D, Dambacher J, Brand S. Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease. Clin Immunol 2008; 127:49-55.
11.01.2008Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease
11.01.2008Clin Immunol 2008; 127:49-55
Seiderer Julia, Reinecker Hans-Christian, Lohse Peter, Ochsenkühn Thomas, Göke Burkhard, Müller-Myhsok Bertram, Jürgens Matthias, Pfennig Simone, Niess Jan-Hendrik, Glas Jürgen, Tillack Cornelia, Leistner Dorothea, Dambacher Julia, Brand Stephan
The role of interleukin-22 in hepatitis C virus infection
Dambacher J, Beigel F, Zitzmann K, Heeg M, Göke B, Diepolder H, Auernhammer C, Brand S. The role of interleukin-22 in hepatitis C virus infection. Cytokine 2008; 41:209-16.
11.01.2008The role of interleukin-22 in hepatitis C virus infection
11.01.2008Cytokine 2008; 41:209-16
Dambacher Julia, Beigel Florian, Zitzmann Kathrin, Heeg Malte H J, Göke Burkhard, Diepolder Helmut M, Auernhammer Christoph J, Brand Stephan
The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population
Glas J, Klein W, Epplen J, Folwaczny C, Lohse P, Göke B, Ochsenkühn T, Mussack T, Folwaczny M, Müller-Myhsok B, Griga T, Haller D, Pfennig S, Konrad A, Schmechel S, Dambacher J, Seiderer J, Schroff F, Wetzke M, Roeske D, Török H, Tonenchi L, Brand S. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population. Am J Gastroenterol 2007; 103:682-91.
20.12.2007The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population
20.12.2007Am J Gastroenterol 2007; 103:682-91
Glas Jürgen, Klein Wolfram, Epplen Jörg T, Folwaczny Christian, Lohse Peter, Göke Burkhard, Ochsenkühn Thomas, Mussack Thomas, Folwaczny Matthias, Müller-Myhsok Bertram, Griga Thomas, Haller Dirk, Pfennig Simone, Konrad Astrid, Schmechel Silke, Dambacher Julia, Seiderer Julia, Schroff Frieder, Wetzke Martin, Roeske Darina, Török Helga-Paula, Tonenchi Laurian, Brand Stephan
C-reactive protein polymorphism and Crohn's disease (Letter to the Editors)
Brand S, Crispin A. C-reactive protein polymorphism and Crohn's disease (Letter to the Editors). Aliment Pharmacol Ther 2007; 25:520-521.
04.10.2007C-reactive protein polymorphism and Crohn's disease (Letter to the Editors)
04.10.2007Aliment Pharmacol Ther 2007; 25:520-521
Brand Stephan, Crispin A
rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants
Glas J, Epplen J, Schiemann U, Folwaczny C, Lohse P, Göke B, Ochsenkühn T, Müller-Myhsok B, Folwaczny M, Mussack T, Klein W, Griga T, Maier K, Seiderer J, Wetzke M, Konrad A, Török H, Schmechel S, Tonenchi L, Grassl C, Dambacher J, Pfennig S, Brand S. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PloS one 2007; 2:e819.
05.09.2007rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants
05.09.2007PloS one 2007; 2:e819
Glas Jürgen, Epplen Jörg T, Schiemann Uwe, Folwaczny Christian, Lohse Peter, Göke Burkhard, Ochsenkühn Thomas, Müller-Myhsok Bertram, Folwaczny Matthias, Mussack Thomas, Klein Wolfram, Griga Thomas, Maier Kerstin, Seiderer Julia, Wetzke Martin, Konrad Astrid, Török Helga-Paula, Schmechel Silke, Tonenchi Laurian, Grassl Christine, Dambacher Julia, Pfennig Simone, Brand Stephan
The role of the selenoprotein S (SELS) gene -105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation
Seiderer J, Lohse P, Ochsenkühn T, Göke B, Haller D, Török H, Konrad A, Pfennig S, Kühnlein B, Dambacher J, Brand S. The role of the selenoprotein S (SELS) gene -105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation. Tissue Antigens 2007; 70:238-46.
01.09.2007The role of the selenoprotein S (SELS) gene -105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation
01.09.2007Tissue Antigens 2007; 70:238-46
Seiderer J, Lohse P, Ochsenkühn T, Göke B, Haller D, Török H-P, Konrad A, Pfennig S, Kühnlein B, Dambacher J, Brand Stephan
Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts
Browning B, Liu X, Mathew C, Müller-Myhsok B, Newman W, Nimmo E, Noble C, Palmieri O, Parkes M, Petermann I, Rutgeerts P, Satsangi J, Shelling A, Siminovitch K, Török H, Tremelling M, Vermeire S, Valvano M, Latiano A, Lakatos P, Lakatos L, Annese V, Barclay M, Bingham S, Brand S, Büning C, Castro M, Cucchiara S, Dallapiccola B, Drummond H, Ferguson L, Ferraris A, Fisher S, Gearry R, Glas J, Henckaerts L, Huebner C, Knafelz D, Witt H. Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts. J Med Genet 2007; 45:36-42.
10.08.2007Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts
10.08.2007J Med Genet 2007; 45:36-42
Browning B L, Liu X, Mathew C, Müller-Myhsok B, Newman W G, Nimmo E R, Noble C L, Palmieri O, Parkes M, Petermann I, Rutgeerts P, Satsangi J, Shelling A N, Siminovitch K A, Török H-P, Tremelling M, Vermeire S, Valvano M R, Latiano A, Lakatos P L, Lakatos L, Annese V, Barclay M L, Bingham S A, Brand Stephan, Büning C, Castro M, Cucchiara S, Dallapiccola B, Drummond H, Ferguson L R, Ferraris A, Fisher S A, Gearry R B, Glas J, Henckaerts L, Huebner C, Knafelz D, Witt H
SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells
Zitzmann K, Brand S, De Toni E, Baehs S, Göke B, Meinecke J, Spöttl G, Meyer H, Auernhammer C. SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells. Cancer Res 2007; 67:5025-32.
15.05.2007SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells
15.05.2007Cancer Res 2007; 67:5025-32
Zitzmann Kathrin, Brand Stephan, De Toni Enrico N, Baehs Sebastian, Göke Burkhard, Meinecke Jennifer, Spöttl Gerald, Meyer Heinrich H H D, Auernhammer Christoph J
Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease
Dambacher J, Beigel F, Seiderer J, Haller D, Göke B, Auernhammer C, Brand S. Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease. Gut 2007; 56:1257-65.
20.04.2007Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease
20.04.2007Gut 2007; 56:1257-65
Dambacher Julia, Beigel Florian, Seiderer Julia, Haller Dirk, Göke Burkhard, Auernhammer Christoph J, Brand Stephan
Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study
Seiderer J, Brand S, Dambacher J, Pfennig S, Jürgens M, Göke B, Ochsenkühn T. Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study. Aliment Pharmacol Ther 2007; 25:787-96.
01.04.2007Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study
01.04.2007Aliment Pharmacol Ther 2007; 25:787-96
Seiderer J, Brand Stephan, Dambacher J, Pfennig S, Jürgens M, Göke B, Ochsenkühn T
The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells
Zitzmann K, De Toni E, Brand S, Göke B, Meinecke J, Spöttl G, Meyer H, Auernhammer C. The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells. Neuroendocrinology 2007; 85:54-60.
19.02.2007The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells
19.02.2007Neuroendocrinology 2007; 85:54-60
Zitzmann Kathrin, De Toni Enrico N, Brand Stephan, Göke Burkhard, Meinecke Jennifer, Spöttl Gerald, Meyer Heinrich H D, Auernhammer Christoph J
IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro
Brand S, Thasler W, Bilzer M, Diepolder H, Göke B, Storr M, Steib C, Olszak T, Prüfer T, Weiss T, Heeg M, Zitzmann K, Beigel F, Dambacher J, Auernhammer C. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. Am J Physiol Gastrointest Liver Physiol 2007; 292:G1019-28.
04.01.2007IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro
04.01.2007Am J Physiol Gastrointest Liver Physiol 2007; 292:G1019-28
Brand Stephan, Thasler Wolfgang E, Bilzer Manfred, Diepolder Helmut, Göke Burkhard, Storr Martin, Steib Christian J, Olszak Torsten, Prüfer Thomas, Weiss Thomas S, Heeg Malte H J, Zitzmann Kathrin, Beigel Florian, Dambacher Julia, Auernhammer Christoph J